Drug CombinationsDrug SynergismDrug Therapy, CombinationDrug InteractionsAntineoplastic Combined Chemotherapy ProtocolsMethenamineProguanilAntimalarialsDapsoneDose-Response Relationship, DrugArtemisininsDrug TherapyAntineoplastic AgentsCell Line, TumorAtovaquoneDrug Screening Assays, AntitumorMethylthioinosineCyclopentolateDrug AntagonismTropicamideCellophaneSulfamethoxazoleDrug ResistancePyrimethamineMefloquinePharmaceutical PreparationsDrug Evaluation, PreclinicalInhibitory Concentration 50FloxuridineMicrobial Sensitivity TestsCisplatinSulfadoxinePyrazinesRifampinMolecular Targeted TherapyCell SurvivalNanoconjugatesAmodiaquineXenograft Model Antitumor AssaysAmikacinChloroquinePhentermineSesquiterpenesTime FactorsFluorouracilApoptosisBoronic AcidsDoxorubicinNaphthoquinonesAntifungal AgentsPyrimidinesFluorenesTreatment OutcomePiperazinesDrug-Related Side Effects and Adverse ReactionsNeoplasmsPlasmodium falciparumDeoxycytidineDrug Administration ScheduleNiacinamideAntitubercular AgentsDrug Resistance, NeoplasmDrug DesignPharmacologyModels, BiologicalAnti-Bacterial AgentsTrimethoprimSystems BiologyDisease Models, AnimalQuinolinesAmphotericin BParasitic Sensitivity TestsMalaria, FalciparumAnti-HIV AgentsPhenylurea CompoundsVincristineCytarabineMedetomidineQuinazolinesDrug Resistance, MultipleAntiprotozoal AgentsClinical Trials as TopicNitroimidazolesClinical Trials, Phase I as TopicDrug DiscoveryPaclitaxelCell ProliferationAntihypertensive AgentsMice, SCIDBenzenesulfonatesPyrazinamideMalariaHydroxamic AcidsItraconazoleTriazinesAntimetabolites, AntineoplasticSignal TransductionTumor Cells, CulturedMice, NudePyridines